BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Seattle Genetics Pages on BioPortfolio:

Biotechnology News Seattle Genetics Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio Biotechnology BioNews : live article
Seattle Genetics Reports Second Quarter 2007 Financial Results and Highlights ... As of June 30, 2007, Seattle Genetics had $132.2 million in cash and ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Biotechnology News Genetics Search
19 Nov 2009 ... Seattle Genetics Bearish Technical Alert - Trend Down 14.6% More .upCom2 UPCOMING EVENTS Learn new strategies, how to trade in this market, ...
http://www.bioportfolio.co.uk/Genetics-news.htm...

Biotechnology News Lymphoma Large-Cell Follicular Search
Seattle Genetics Announces Discontinuation Of Dacetuzumab Phase IIb Diffuse Large B-Cell Lymphoma Clinical Tri Seattle Genetics, Inc. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Biotechnology News pancreatic cancer Search
Seattle Genetics Initiates Phase I Clinical Trial of Antibody-Drug ... (Business Wire) Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has ...
http://www.bioportfolio.co.uk/pancreatic%20cancer-news.htm...

Biotechnology News Targeted Genetics Search
(SGEN) Seattle Genetics (NASDAQ:SGEN) is trading 2.3% lower (down $0.22 to $9.50 ) today on volume of 147384 shares. The stock has traded within a 52-week ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio's NASDAQ Top Biotech Companies News Feed
PROTEIN DESIGN LABS INC · REGENERATION TECHNOLOGIES · REGENERON PHARMACEUTICALS · REPLIGEN CORPORATION · SANGAMO BIOSCIENCES INC · SEATTLE GENETICS INC /WA ...
http://www.bioportfolio.co.uk/news/nasdaq_top_bio150_1.shtml...

BioPortfolio's Lymphoma News and Headlines
Seattle Genetics Initiates Phase I Clinical Trial Of Antibody-Drug Conjugate SGN -75 ... Seattle Genetics Initiates Phase I Clinical Trial of Antibody-Drug ...
http://www.bioportfolio.co.uk/Health_News/Lymphoma.shtml...

BioPortfolio - Seattle Genetics
Seattle Genetics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/9307-Seattle_Geneti...

Biotechnology News CARBOPLATIN Search
Seattle Genetics discontinues Phase IIb lymphoma trial. Seattle Genetics, a biotechnology company, has discontinued the SeaGen Mariner clinical trial based
...
http://www.bioportfolio.co.uk/CARBOPLATIN-news.htm...

Results from other life science and pharmaceutical sites:

SGEN: Profile for Seattle Genetics, Inc. - Yahoo! Finance
See the company profile for Seattle Genetics, Inc. (SGEN) including business summary, industry/sector information, number of employees, business summary, ...
http://biz.yahoo.com/p/s/sgen.html...

Seattle Genetics, Inc. - Google Finance
Get the latest on Seattle Genetics, Inc. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=NASDAQ:SGEN...

BioSpace - Seattle Genetics, Inc. News, Search Jobs, Events
At Seattle Genetics, we are committed to developing innovative antibody-based therapies that improve clinical outcomes for patients with cancer and ...
http://www.biospace.com/company_profile.aspx?CompanyId=3510...

Seattle Genetics Inc. - Company Profile - BioCentury
Seattle Genetics' detailed financials; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma
industry ...
http://www.biocentury.com/companies/Seattle_Genetics_Inc?utm...



...

Targeted Genetics Corporation
Targeted Genetics at Rodman & Renshaw Annual Global Healthcare Conference ... 10 /1/2009, Nasdaq Grants Targeted Genetics Corporation an Extension to Regain ...
http://www.targen.com/...

Seattle Genetics Highlights Pipeline Progress and Reports Third ...
22 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) today reported financial results for the third quarter and nine ...
http://biz.yahoo.com/bw/091022/20091022006387.html?.v=1...

News: Seattle Genetics Shutters B-Cell Lymphoma Program.
5 Oct 2009 ... Dacetuzumab is a humanized mAb that targets the CD40 antigen, which is expressed on most B lineage hematologic malignancies as well as some ...
http://www.genengnews.com/news/bnitem.aspx?name=64625433...

Seattle Genetics to Present at Upcoming Investor Conferences ...
27 Oct 2009 ... BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN - News) announced today that management will present at two upcoming ...
http://biz.yahoo.com/bw/091027/20091027006241.html?.v=1...

Seattle Genetics, Inc. Stops Mid-Stage Cancer Trial - News, Search ...
6 Oct 2009 ... (BUSINESS WIRE)--Seattle Genetics, Inc. announced today that it has discontinued the SeaGen MARINER clinical trial based on a determination ...
http://www.biospace.com/news_story.aspx?NewsEntityId=157986...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.